These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19946620)

  • 1. Clinical and molecular aspects of varicella zoster virus infection.
    Gilden D; Nagel MA; Mahalingam R; Mueller NH; Brazeau EA; Pugazhenthi S; Cohrs RJ
    Future Neurol; 2009 Jan; 4(1):103-117. PubMed ID: 19946620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological disease produced by varicella zoster virus reactivation without rash.
    Gilden D; Cohrs RJ; Mahalingam R; Nagel MA
    Curr Top Microbiol Immunol; 2010; 342():243-53. PubMed ID: 20186614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella Zoster Virus in the Nervous System.
    Gilden D; Nagel M; Cohrs R; Mahalingam R; Baird N
    F1000Res; 2015; 4():. PubMed ID: 26918131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella virus-mononuclear cell interaction.
    White TM; Gilden DH
    Adv Virus Res; 2003; 62():1-17. PubMed ID: 14719363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella zoster virus latency, neurological disease and experimental models: an update.
    Cohrs RJ; Gilden DH; Mahalingam R
    Front Biosci; 2004 Jan; 9():751-62. PubMed ID: 14766405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular pathogenesis of varicella virus infection.
    Gilden DH; Cohrs RJ; Mahalingam R
    Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of varicella zoster virus reactivation.
    Nagel MA; Gilden D
    Curr Treat Options Neurol; 2013 Aug; 15(4):439-53. PubMed ID: 23794213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation.
    Kennedy PGE
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37632006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of shingles: safety and efficacy of live zoster vaccine.
    Quan D; Cohrs RJ; Mahalingam R; Gilden DH
    Ther Clin Risk Manag; 2007 Aug; 3(4):633-9. PubMed ID: 18472986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 46-year-old female presenting with worsening headache, nuchal rigidity and a skin rash in varicella zoster virus meningitis: a case report.
    Kushawaha A; Mobarakai N; Tolia J
    Cases J; 2009 Sep; 2():6299. PubMed ID: 19918571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of Varicella-Zoster Virus Infection.
    Kennedy PGE; Gershon AA
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy.
    Gilden DH; Cohrs RJ; Mahalingam R
    Neurology; 2005 Jan; 64(1):21-5. PubMed ID: 15642898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenging patient with varicella-zoster virus disease.
    Nagel MA; Gilden D
    Neurol Clin Pract; 2013 Apr; 3(2):109-117. PubMed ID: 23914320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV).
    Kennedy PG
    Neurotherapeutics; 2016 Jul; 13(3):509-13. PubMed ID: 27032406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation.
    Baird NL; Zhu S; Pearce CM; Viejo-Borbolla A
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30691086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Harpaz R; Ortega-Sanchez IR; Seward JF;
    MMWR Recomm Rep; 2008 Jun; 57(RR-5):1-30; quiz CE2-4. PubMed ID: 18528318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella-zoster virus: overview and clinical manifestations.
    Arvin AM
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):4-7. PubMed ID: 8840410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models.
    Kinchington PR; Goins WF
    J Neurovirol; 2011 Dec; 17(6):590-9. PubMed ID: 22205584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.